Observational analysis showed improved long-term prognosis in heart failure patients, indicating integrated management benefits.
Premises and Purpose of the study: Heart failure constitutes a significant health problem given its high prevalence, the frequency of re-hospitalizations and severe disability, which often entail high social costs. The day-hospital for heart failure, allows the structuring of a rehabilitation project, at ensuring the multidisciplinary nature and continuity of care.Materials and Methods: 160 patients with heart failure were admitted to a day hospital during 12/30/2022-12/31/2023 for follow-up, after hospitalization at our Internal Medicine Unit. Management was integrated with general practitioners, after conducting an initial evaluation both at discharge and 30 days later.Results: Mean age 79.7±8.5; males (58.1%), females (41.2%). Hb:11,9±0.4; creatinine 1.4±0.3; CrCl 43.8±12.5; K. 4.0±0.8; SBP 122.3±; DBP 70.9±9.6; BMI 24.7±4.7. HFrEF 44.3% (EF% 35.5±2.5). HFmrEF 13.7% (EF% 46.4±2.1). HFpEF 43.1% (EF% 62.2±5.0); BNP at baseline and 30 days (551.3 vs. 271.9); NT-proBNP at baseline and 30 days (1352.9 vs. 853.2). Comorbidities: CAD (32.5), CKD (48.5%), COPD (27.5%), Anemia (40.3%), Diabetes (33.1%), Hypertension (62.5%), AF (35%). Treatment: ACE/ARNI (89.9%), BB (86.3%), MRA (48.5%), diuretics (87.5%), digitalis (12.5%), amiodarone (22.0%), NAO (33.6%)Conclusions: A day hospital follow-up approach, after discharge, in patients with congestive heart failure, can improve long-term prognosis. The results, do not seem to depend on any adjustment of the drug. Natriuretic peptides (NPs) represent one potentially appealing strategy, to personalize the approach.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: